All In MedTech

Company

Axogen

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

AXGN

Nasdaq · Axogen, Inc.

Public float

$431M

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$225M

Fiscal year ending Dec 31, 2025

Net income

-$15.7M

Fiscal year ending Dec 31, 2025

R&D spending

$32.9M

Fiscal year ending Dec 31, 2025

Cash

$329M

As of Sep 30, 2026

Long-term debt

$0

As of Sep 30, 2026

Shares outstanding

59.7M

As of Oct 26, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2021––$15.0M–

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Sep 30, 2011Equity

Issued in a merger or acquisition; not counted as money raised

$1.0M$1.0M11Rule 506Form D ↗Oct 13, 2011
May 3, 2011Debt

Issued in a merger or acquisition; not counted as money raised

$3.0M$5.5M13Rule 506Form D/A ↗Jun 15, 20111 amendment
Jun 11, 2010Convertible note$3.7M$3.7M11Rule 506Form D/A ↗Jan 12, 20111 amendment

1 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
AxoGen, Inc.; AXOGEN CORP
Headquarters
Texarkana, Texas
Incorporated
Minnesota over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    11 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is part of the paid tier

    For Axogen we have 2 shareholders with 5% or more.

    It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

    Latest FDA decisions

    Search the Clearance Tracker

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    3 more trials with a free account

    Reports received

    23

    Received Nov 1, 2025 to Nov 19, 2026

    Malfunction reports

    0

    0.0% of reports

    Injury reports

    23

    100% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230000
    Jan 240000
    Feb 240000
    Mar 241000
    Apr 240000
    May 240100
    Jun 240100
    Jul 240000
    Aug 240100
    Sep 240100
    Oct 240100
    Nov 240300
    Dec 240100
    Jan 250000
    Feb 250000
    Mar 250000
    Apr 250100
    May 250300
    Jun 250100
    Jul 250100
    Aug 250100
    Sep 250300
    Oct 250300
    Nov 250200
    Dec 250200
    Jan 260000
    Feb 260100
    Mar 260100
    Apr 260300
    May 260200
    Jun 260300
    Jul 260000
    Aug 260000
    Sep 260700
    Oct 260200
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    No recalls under this name in FDA's data.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.